Corinne Le Goff

Celsion Corp

Biopharmaceutical leader Corinne Le Goff is President and CEO of clinical-stage biotech firm Celsion Corp. She brings decades of global healthcare leadership experience to the company across various therapeutic areas, as well asvast experience in developing and launching successful drugs from her tenure at both large pharma firms and small biotech companies. Corinne joined Celsion from Moderna where she most recently served as Chief Commercial Officer and was responsible for developing the capabilities necessary to ensure the global distribution of Moderna’s Covid-19 vaccine. She also led the development of the mRNA platform long-term commercial strategy. Prior to Moderna, she worked at Amgen for six years, most recently as President of the US Business, driving growth strategy; and before that, she held various senior international roles at Roche, including President of Roche France. She earned a PhD in pharmaceutical sciences from Rene Descartes University in Paris and an MBA from Sorbonne University and INSEAD.s

Year appointed: July 2022